Brown Brothers Harriman & Co. »

iShares Dow Jones US Pharm Indx shares owned by Brown Brothers Harriman & Co.

Quarter-by-quarter ownership of iShares Dow Jones US Pharm Indx (IHE) shares owned by Brown Brothers Harriman & Co. from 13F filings

Historical chart of Brown Brothers Harriman & Co. investment in iShares Dow Jones US Pharm Indx

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Pharm Indx held by Brown Brothers Harriman & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Pharm Indx by Brown Brothers Harriman & Co.

Quarter filed Position value Share count Share price at filing
2023-12-31 $42k 225 185.40
2023-09-30 $40k 225 176.98

More positions owned by Brown Brothers Harriman & Co.

Berkshire Hathaway Inc-cl B Common Stock (BRK.B)
Microsoft Corp Common Stock (MSFT)
Alphabet Inc-cl C Common Stock (GOOG)
Linde Common Stock (LIN)
Mastercard Inc - A Common Stock (MA)
Zoetis Common Stock (ZTS)
Waste Management Common Stock (WM)
Oracle Corp Common Stock (ORCL)
Kla Corp Common Stock (KLAC)
Progressive Corp Common Stock (PGR)
Arthur J Gallagher & Co Common Stock (AJG)
Alcon Common Stock (ALC)
Amazon.com Common Stock (AMZN)
Booking Holdings Common Stock (BKNG)
Thermo Fisher Scientific Common Stock (TMO)

View all positions for Brown Brothers Harriman & Co.

Top funds holding iShares Dow Jones US Pharm Indx

Fisher Investments
Accurate Wealth Management
Brown Advisory Holdings Incorporated
Bank of America Corporation
Raymond James & Associates
Royal Bank of Canada
Southern Capital Advisors
Commonwealth Equity Services
Citadel Advisors
Wells Fargo & Company
Massachusetts Wealth Management
UBS Group
Raymond James Financial Services Advisors
Goldman Sachs Group
Janney Montgomery Scott

View all funds holding iShares Dow Jones US Pharm Indx